Condition
Hypogonadism; Ovarian
Total Trials
4
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 4 (2)
Trial Status
Recruiting3
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT06570460Phase 4Recruiting
Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome
NCT06544473Phase 4Recruiting
Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome
NCT04760574RecruitingPrimary
Association Between Human Immunodeficiency Virus (HIV) Infection and Male Hypogonadism
NCT03080584Not ApplicableUnknownPrimary
Effect of 12 Weeks of Acupuncture on AMH and COH in Low Responder Patients
Showing all 4 trials